NK Cell Therapy for Malignant Solid Brain Tumors
NK Cell Therapy for Malignant Solid Brain Tumors
Recruiting · NCT07552233 · Registry updated 2026-04-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NK Cell Therapy for Malignant Solid Brain Tumors | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, anaplastic meningioma, astrocytoma (excluding glioblastoma), brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioblastoma, glioma, meningioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor, tumor of meninges, vascular cancer | Recruiting | Not applicable | 2026-04-27 | NCT07552233 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Henan Academy of Innovations in Medical Science | Zhengzhou | China | 2 |
| Peking University Third Hospital | Beijing | China | 123 |
| Qinhuangdao Runze Hospital | Qinhuangdao | China | 1 |
| Zhengzhou Second Hospital | Zhengzhou | China | 2 |